Data / Form D filings / INHIBITEX, INC.
INHIBITEX, INC.: Form D filing
INHIBITEX, INC., a biotechnology company in Alpharetta, GA, filed a Form D with the SEC in 2009. The latest, on November 9, 2009, reports $23 million sold of a $23 million offering to 12 investors.
Find out what INHIBITEX, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9005 Westside Parkway, Alpharetta, GA, 30009
- Phone
- (678) 746-1100
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $1,000,001 - $5,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1274913
The full lists. Form D filings in Georgia: 1,337 rows, $66.85, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 9, 2009 | New notice | $23,000,000 | $23,000,000 | $0 | 12 | Oct 28, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| M. James M. Barrett | Director | |
| Chris M. McGuigan | Director | |
| Russell M. Medord | Director | |
| Marc L. Preminger | Director | |
| Gabriele M. Cerrone | Director | |
| Joseph M. Patti | Executive Officer | |
| Geoffrey W. Henson | Executive Officer | |
| A. Keith L. Willard | Director | |
| Michael M. Henos | Director | |
| Russell H. Plumb | Executive Officer, Director |
Other biotechnology companies in Georgia that filed recently
- Opus Medical Therapies, LLC $485,089 · Sep 22, 2026
- Airway Therapeutics, Inc. $43.5 million · Sep 9, 2026
- FEMASYS INC $30 million · Aug 20, 2026
Every Form D from the week of Nov 9, 2009 · All recent filings in Georgia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what INHIBITEX, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.